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Abstract
Background: Mortality rates due to coronary heart disease (CHD) have decreased in most countries, but increased
in low and middle-income countries. Few studies have analyzed the trends of coronary heart disease mortality in
Latin America, specifically the trends in young-adults and the effect of correcting these comparisons for nonspecific
causes of death (garbage codes). The objective of this study was to describe and compare standardized, age-
specific, and garbage-code corrected mortality trends for coronary heart disease from 1985 to 2015 in Argentina,
Colombia, and Mexico.
Methods: Deaths from coronary heart disease were grouped by country, year of registration, sex, and 10-year age
bands to calculate age-adjusted and age and sex-specific rates for adults aged ≥25. We corrected for garbage-
codes using the methodology proposed by the Global Burden of Disease. Finally, we fitted Joinpoint regression
models.
Results: In 1985, age-standardized mortality rates per 100,000 population were 136.6 in Argentina, 160.6 in Colombia,
and 87.51 in Mexico; by 2015 rates decreased 51% in Argentina and 6.5% in Colombia, yet increased by 61% in Mexico,
where an upward trend in mortality was observed in young adults. Garbage-code corrections produced increases in
mortality rates, particularly in Argentina with approximately 80 additional deaths per 100,000, 14 in Colombia and 13 in
Mexico.
Conclusions: Latin American countries are at different stages of the cardiovascular disease epidemic. Garbage code
correction produce large changes in the mortality rates in Argentina, yet smaller in Mexico and Colombia, suggesting
garbage code corrections may be needed for specific countries. While coronary heart disease (CHD) mortality is falling in
Argentina, modest falls in Colombia and substantial increases in Mexico highlight the need for the region to propose and
implement population-wide prevention policies.
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Background
Coronary heart disease (CHD) has been the leading
cause of death worldwide since 1970, accounting for 7.3
million deaths in 2010 and 13% of global mortality [1].
The current distribution of CHD responds to a large re-
duction in CHD deaths in high-income countries, and
mixed trends in low and middle income countries
(LMIC) [1, 2]. In most European countries a 30% decline
in CHD deaths was registered from 1980 to 2010; similar
reductions were observed in the US, Canada, and
Australia, where CHD rates are now less than half of
1980s rates [3, 4]. In contrast, increasing trends were ob-
served in Eastern Europe, Asian and Latin-American
countries [4–7]. Differences in trends have been ex-
plained by changes in the prevalence of risk factors and
differential access to treatments [3, 5, 8–12].
The behavior of the CHD epidemic not only differs
across countries, but across age groups. A recent discus-
sion has arisen about the possibility that CHD mortality
in young adults could be stabilizing or even increasing.
While in the US, UK and Australia, CHD mortality in
young adults (< 55 years) seems to be decreasing or
remaining constant [3, 10, 13], this behavior is not com-
mon to all high income countries, and some of them are
actually experiencing increases [14]. In the case of
LMIC, little is known about mortality in young adults.
In a recent study in Latin America on adults aged 35–
44 years, most countries showed declining trends, except
for Mexico and Panama [7]. In this study, the highest
decreases in CHD mortality rates in men between 2001
and 2013 were in Ecuador (46% from 12.6 to 6.8 per
100,000), Puerto Rico (32% from 16.7 to 11.3 per 100,
000) and Argentina (28% from 14.8 to 10.6 per 100,000)
[7]. In the case of women, the highest decreases were in
Ecuador (59% from 5.2 to 2.1 per 100,000), Uruguay
(51% from 4.3 to 2.1 per 100,000), Colombia (35% from
7.1 to 4.7 per 100,000) and Cuba (35% from 7.4 to 4.8
per 100,000) [7]. In contrast, Panama showed the highest
increases in both sexes (42% in men and 52% in women)
followed by Mexico (18% in men and 4% in women) [7].
Although the changes in Panama were higher, the CHD
mortality rates are still lower in Panama than in Mexico
for both sexes in this age-group [7].
Latin America shows complex patterns for CHD mor-
tality. Countries are at different stages of the CHD epi-
demic, and while most of them show declines some others
are experiencing increases [4, 7, 15]. Some studies have
analyzed age- and sex-specific mortality rates [7, 15, 16];
however, they have studied age-groups by life stages,
which are not as detailed as decennial age groups. Also,
studies tend to exclude adults younger than 35 years old.
Understanding how mortality trends evolve over a long
period is crucial to further understand potential drivers of
the epidemic at a national level. Importantly, previous
studies looking at mortality trends did not consider the
differential quality of death registries across Latin Ameri-
can countries, an aspect that could account for some of
the observed trend differences.
We aimed to examine and compare age-adjusted, age-
and sex-specific, and garbage code corrected mortality
trends for CHD from 1985 to 2015 in three Latin
American countries: Argentina, Colombia, and Mexico.
These countries are in the top-five gross domestic prod-
uct in the region and have comparable health investment
[17–19]. They also have marked differences in data qual-
ity and CHD mortality levels in 1985: Mexico with low,
Argentina intermediate and Colombia at high mortality
rates. We analyzed the mortality rates of these countries
to contrast age- and sex-specific differences, specifically
to evaluate the hypothesis that CHD mortality has stag-
nated in young adults. Finally, we aimed to analyze the
influence of garbage-code correction in this comparison.
Methods
Demographic and mortality data were obtained from the
World Health Organization (WHO) database [20]. The
underlying cause of death from coronary heart disease
was determined using the International Classification of
Diseases (ICD), codes 410–414 from the 9th and codes
I20-I25 from the 10th revision, all codes were pooled to-
gether in a category of “all coronary heart diseases”. Data
for all CHD deaths (1985–2015) in the 3 countries were
grouped by year, sex and age (decennial group) for
adults aged 25 years and over.
Age and sex-specific mortality rates were calculated as
the number of deaths in each age-sex group by the total
number of persons in the population group per 100,000
inhabitants per year and country. Age standardization of
rates was achieved through the direct method, multiply-
ing the age-specific mortality rates by the proportion of
people in each age group in the world standard popula-
tion [21]. This methodology was repeated within each
sex to obtain age standardized rates by sex.
Standardized CHD mortality rates and age and sex
specific mortality rates for each country were analyzed
using joinpoint regression to identify years at which
changes in mortality trends occurred [22, 23]. Joinpoint
regression is a statistical method used to identify years at
which changes in mortality trends occurred. The esti-
mated annual percentage change (APC) was computed
by fitting a regression line to the natural logarithm of
the rates and using the calendar year as an independent
variable. A 95% confidence interval for the APC was also
computed. We used a Bayesian Information Criterion
(BIC) approach to select the model that best fitted the
data. The analysis was performed using software devel-
oped by the Surveillance Research Program of the US
National Cancer Institute (Joinpoint version 3.4.1) [24].
Arroyo-Quiroz et al. BMC Public Health          (2020) 20:162 Page 2 of 10
We performed an analysis to quantify how garbage-
codes influenced mortality rates. The term “garbage-
codes” (GC) has been used for mortality codes that cor-
respond to causes that are not useful for the analysis of
deaths in public health, since they are ambiguous or
nonspecific, or refer to symptoms or intermediate causes
[25, 26]. Methods to redistribute GC have been pro-
posed. Previous studies have shown that CHD mortality
rates are particularly prone to changes after redistribu-
tion [27, 28].
Garbage-code information was determined using codes
428, 428.0, 428.1 and 428.9 for ICD 9 and codes I50,
I50.0 I50.1 I50.9 for ICD 10 (Appendix). All codes were
pooled together into one category (GCMort), data in
every country were grouped by year, sex and age (10-
year groups) for adults aged ≥25 years. Argentina and
Colombia had information from 1997 to 2015, so we re-
stricted our analysis to this period. Garbage-code cor-
rected mortality was estimated according to the Global
Burden of Disease (GBD) methodology [27, 28] in
which:
CHDMortCorrected ¼ CHDMortO þ δGCMort
Where.
CHDMortCorrected is CHD mortality corrected by gar-
bage codes;
CHDMort0 is the original CHD mortality;
δ is the redistribution percentage of garbage code by
age and sex group according to GBD methodology and;
GCMort is the garbage code mortality related to CHD.
The redistribution percentage (δ) for the age group
from 15 to 49 years in developing countries was 72 and
47% for men and women respectively, for the group over
50 the percentage was 74% for men and women [28].
Standardized mortality rates and age and sex specific
garbage-code corrected mortality rates for each country,
were obtained and analyzed using joinpoint regression in
order to compare them with the uncorrected rates. Fi-
nally, we compared the garbage-code corrected and the
original CHD mortality rates for every country, sex and
age-group using the Kruskal-Wallis non-parametric test.
Ethical consideration
Our study is a secondary analysis of existing data from
the World Health Organization (WHO) mortality data-
base. The datasets used for this study are publicly avail-
able and anonymous.
Results
In 1985, mortality rates were higher in Colombia (160.6
per 100,000) and Argentina (137.6 per 100,000) and
lower in Mexico (86.5 per 100,000). Between 1985 and
2015 age-adjusted CHD mortality rates declined in
Colombia (6.5%) and Argentina (51.1%) but increased in
Mexico by 60.8% (Fig. 1). By 2015, mortality rates were
highest in Colombia (150.7 per 100,000), followed by
Mexico (140.8 per 100,000) and Argentina (67.3 per 100,
000). The steepest decline was observed in Argentinian
women and the sharpest increase in Mexican men. In all
countries, men had higher mortality rates than women
during the study period; in Colombia, the difference be-
tween men and women remained parallel and un-
changed, in Argentina the gap between men and women
decreased, while in Mexico the initial gap between men
and women kept increasing.
The decline in CHD mortality rates was more pro-
nounced in Argentina, where women had stronger re-
ductions than men (53% vs 48.6%). Four joinpoints were
obtained in the analysis by sex (Table 1 in Appendix).
The largest reductions were observed between 1985 and
1994 for both men (APC -4.9; 95%CI -6.5, − 3.4) and
women (APC -6.7; 95%CI -9.3, − 4.1). From 2008 to
2015, CHD mortality in Argentina seems to have stabi-
lized (APC 0.2; 95%CI -0.9, 1.2).
In Colombia, a small reduction in CHD mortality was
observed on average over the 1985–2015 period, for
both men (1.9%) and women (9.8%). In women, at the
beginning of the period, from 1985 to 2012, the APC
was negative (APC -2.5; 95%CI -3.3, − 0.7), but became
positive in the 2012 to 2014 period (APC 1.1; 95%CI
-1.6, − 0.6). In men, we observed an initial negative trend
from 1985 to 2003 (APC -0.7; 95%CI -1.1, − 0.4), a
stabilization period from 2003 to 2011 with little change,
followed by an increasing trend from 2011 to 2015 (APC
4.7; 95%CI 2.3, 7.2).
From 1985 to 2015, the global increase over the study
period in Mexico was 80.6% in men and 41.9% in
women. In the joinpoint analysis, five changes in trend
were obtained for both men and women. The highest in-
crease in CHD mortality in men was observed between
1987 and 1990 (APC 9.3; 95%CI 0.4, 19), while for
women it was from 1985 to 1989 (APC 6.6; 95%CI 2.6,
10.7). From 1996 to 2007 mortality stabilized in men,
while a significant decline was observed in women (APC
-0.8; 95%CI -1.4, − 0.1). From 2007 to 2015 men experi-
enced a small significant increase (APC 2.5; 95%CI 1.9,
3). Women had a significant increase from 2007 to 2012
(APC 1.8; 95%CI 1, 2.5).
In Argentina and Colombia age- and sex-specific mor-
tality trends were similar across strata (Table 2 in
Appendix). However, two groups showed important dis-
crepancies (Fig. 2): (i) Argentinian men and women aged
25–34 had a non- significant increase in mortality at the
end of the period studied (APC 1.8; 95%CI − 1.9, 5.6 and
APC 1.9; 95%CI 4, 8.1 respectively); and (ii) Colombians
aged 75 and more had an initial decrease in rates from
1985 to 1988, followed by a sharp increase (men from
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2011 to 2015 APC 8.3; 95%CI 5.5, 11.3; women from
2012 to 2015 APC 8.1; 95%CI 4, 12.4).
In the case of Mexico, some age- and sex-specific
groups differed from the average trends. Mexican men
aged 25–34 experienced an increase in mortality rates
during most of the study period; the highest increase
was observed from 2000 to 2010 (APC 5.2; 95%CI 3.8,
6.7), there was also a positive trend from 2013 to 2015,
but it was non-significant (APC 6.5; 95%CI -5.7, 20.3).
Mortality rates in young Mexican women aged 25–34
had a small significant increase between 1998 and 2013
(APC 1.2; 95%CI 0.3, 2.2). In men and women aged 35
and older, mortality rates kept increasing during the
study period, particularly in those aged 75 and older, the
largest increases in these age groups were observed be-
tween 1987 and 1990 in men (APC 19.3; 95%CI 6.1,
34.2) and 1987–1989 in women (APC 7.6; 95%CI 2.7,
12.8).
Garbage-code correction had an important influence
on the intercepts of the trends but little effect on the
slopes (see Fig. 3). In Argentina, garbage-code correction
produced an increase in the number of cases across the
Fig. 1 Trends in age-standardized mortality rates per 100,000 by sex for coronary heart disease. Argentina, Colombia, and México. 1985–2015.
Star: all; circle: male; cross: female
Fig. 2 Trends in age and sex-specific mortality rates per 100,000 for Coronary Heart Disease, by country. Argentina, Colombia, and México. 1985–
2015. Circle: male; cross: female
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study period: on average, per year there were approxi-
mately 77 additional deaths per 100,000, compared with
12.5 additional deaths in Colombia and 12.8 in Mexico.
The differences between the corrected and the original
mortality rates were significant in the case of Argentin-
ian men and women; in contrast, the differences in
Colombia and Mexico were not significant (Table 2 in
Appendix). Relative to the original rates, garbage-code
correction implied an average increase in rates of 104.6%
in Argentina, 9.4% in Colombia and 10.2% in Mexico. In
Argentina, garbage-code corrections increased mortality
rates in men by 83.8%, compared to 140.4% in women
(Table 2 in Appendix); these large differences were not
observed in Colombia (men 8.5%, women 10.6%) or
Mexico (men 8.2%, women 12.8%). While studying age
and sex-specific mortality rates (Fig. 4), in the three
countries the increases due to the correction were higher
in the youngest and oldest age-groups. Women in the
three countries tend to have a higher percentage of
change after correction than men.
Discussion
We aimed to study mortality trends in three Latin
America countries between 1985 and 2012 and we found
that disparities remain: age-adjusted CHD mortality
rates declined in Argentina and Colombia (51.1 and
6.5% respectively) and increased in Mexico (60.8%).
Trends in young adults (< 35 years old) had a significant
increment in the last decade in Mexico for men and
women, but not in Argentina or Colombia. Garbage-
code corrections produced dramatic increases in
mortality rates in Argentina, particularly in women and
amongst the young adults and the elderly.
Our results in changes in CHD mortality trends are
consistent with those previously reported [7, 16], al-
though some important differences in magnitude could
be explained by the study period and age-groups consid-
ered. Pagan, et.al., studied mortality rates from 2000 to
2012 for adults 36 to 64 years old and had a similar be-
havior to what we observed in the three countries in the
same period [7]. In Argentina, they observed a smaller
reduction (19% men, 15% women) than ours (25% men,
24% women). In Colombia, the magnitude of the change
was very similar, around zero for men in both studies
and a 5% reduction in women (6% in our study). There
are differences in both magnitude and direction in
Mexico in this period. They reported an increase of 6%
in men, which is lower than the 15% we found. In
women, they reported a decrease of 6% and we found an
increase of 5% [7]. These differences could be explained
by the behavior of mortality in the younger and older
groups, which were not included in their study.
The epidemic pattern experienced by Argentina is
comparable to that reported in USA, Canada, France,
Uruguay, Panama and the United Kingdom who experi-
enced CHD mortality increases up to 1970, to be
followed by a steady decrease since then [4]. The de-
creasing magnitude is similar to that in France and
Estonia with a total percentage change between 46 and
50 in men and 53–55 in women [4]; in contrast,
Uruguay and Panama also had decreases, but the magni-
tude was around 30%. Mortality rates in Colombia are
also decreasing but at a smaller pace, percentage change
Fig. 3 Trends in adjusted age-standardized mortality rates per 100,000 by sex for coronary heart disease corrected by garbage codes. Argentina,
Colombia, and México. 1997–2015. Gray: original mortality rates; black: garbage-codes corrected mortality rates. Star: all; circle: male; cross: female
Arroyo-Quiroz et al. BMC Public Health          (2020) 20:162 Page 5 of 10
on the overall period was 13.2% in men and 21.7% in
women. In magnitude, these mortality rate reductions
are comparable to those observed in Bulgaria, where
total percentage change was 14.3 and 21.5 for men
and women, respectively [4]. In the case of Latin
American countries, Venezuela had similar changes to
Colombia for mortality in women [7]. In contrast,
CHD mortality rates in Mexico are still rising. These
epidemic patterns are similar to those reported in the
Russian Federation, Ukraine, and Latvia before 2002,
although the magnitude of the increase in CHD mor-
tality rates in these countries was higher [14]. In El
Salvador, Sri Lanka and the Philippines both, epi-
demic form and magnitude changes, were similar to
those in Mexico [7, 29].
Age and sex specific trends in Colombia, Mexico
and Argentina are complex, but trends in young
adults in Argentina and Mexico are worrisome. Very
young Mexican adults (< 35 years) showed an increase
in CHD mortality in the last decades. Mexican men
35–44 also had an increase in the study period, but
the increase rate was lower. Stagnation of trends was
observed only in very young Argentinian men, but it
was not observed in the group of adults aged 35–44.
Finally, in the Colombian population, CHD mortality
rates tended to decrease in both age groups. Few
studies have analyzed changes in the mortality trends
in young adults and only some of them have found
this increase or stagnation [3, 7, 10, 11]. A study
conducted in 26 European countries concluded that
in most countries the decline rate observed in youn-
ger age groups is similar to that observed in older
populations [14]. However, in a small number of
countries, like the United Kingdom or the United
States, the population under 55 years have experi-
enced smaller decreases in CHD mortality rates since
1990 than those observed in previous years and older
age groups [3, 10]. In the analysis performed by
Pagan, et.al., Latin America rate increases in men
were observed in Costa Rica, Mexico, and Panama,
while for women they were only observed in Mexico
and Panama [7]. This analysis was restricted to the
35 to 44 years group, while we observed declines in
the Mexican population and stagnation in Argentinian
men aged 35 years and under.
Several reports have warned against the crude com-
parison of CHD mortality rates across countries without
considering the quality of death certificates. All previous
studies comparing rates across Latin America have
reached the conclusion that Argentina is experiencing
one of the lowest CHD mortality rates. However, after
garbage-code correction, we observed that Argentina
was not a low risk country at the beginning of the study
period, with rates comparable to Mexico or Colombia.
Garbage-code correction in these countries did not
affect slopes, suggesting that the quality of reporting for
CHD has not changed between 1997 and 2015. Presum-
ably, garbage codes are more commonly used in the
Fig. 4 Trends in age and sex-specific mortality rates per 100,000 for Coronary Heart Disease corrected by garbage codes, by country. Argentina,
Colombia, and México. 1997–2015. Gray: original mortality rates; black: garbage-codes corrected mortality rates. Circle: male; cross: female
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youngest and oldest members of the population because
they are unspecific. It is difficult to diagnose coronary
heart disease in very young adults because it is a chronic
disease and it is uncommon to develop it at younger
ages. On the other hand, elderly people might have more
than one underlying disease and unspecific codes sim-
plify the selection of the underlying cause of death. It is
important to mention that while the method for
garbage-code correction used in our paper has shown to
be consistent throughout multiple studies [27, 28], no
method has been established as the “gold standard” and
errors in the comparison across countries could still
remain.
Previous studies suggest that only a few countries have
good-quality on CHD mortality statistics, requiring cor-
rection methods to adjust for CHD registry limitations
[25, 28]. In our study, we confirmed that the garbage-
code correction is fundamental to improve the compari-
son of CHD mortality patterns. In our case, the correc-
tion particularly affected Argentina, where a high
proportion of records were coded with unspecific mor-
tality codes; yet, in countries with better quality of data,
such as Colombia and Mexico, the correction produced
smaller changes. We strongly recommend the use of the
correction method while analyzing CHD mortality
trends, unless there is certainty about the reliability of
CHD mortality coding. Countries need to promote the
improvement of CHD mortality registration, highlighting
the importance of accurate registry for policy decision
making and evaluation [25, 27].
The three countries included in this analysis are
upper-middle income countries with similar life expect-
ancy at birth and demographic distribution [17–19]. Fur-
thermore, the three of them experienced the
epidemiological transition in the last decades of the
twentieth century [30, 31]. However, there are some im-
portant differences: at the beginning of the study period
CHD was the main cause of death in the three countries
and, at the end of the period, diabetes was the main
cause of dead in Mexico [18].
To our knowledge, no study on the contribution of
risk factors to changes in CHD mortality in Latin Amer-
ica has been conducted. One study in Argentina ana-
lyzed the contribution of changes in risk factors and
treatments in CHD mortality trends [32]. In this study,
the authors found that evidence-based therapies
accounted for approximately 49% of the deaths pre-
vented or postponed; in contrast, changes in risk factors
trends accounted only for 32.6% [32]. Although the main
changes are due to medical treatments, especially hyper-
tension treatments and secondary prevention after AMI,
the reduction of three key risk factors could help to ex-
plain changes in mortality in Argentina: an important
fall in hypertension prevalence (34.6%) [32], a 7%
decrease in the smoking prevalence between 1980 and
2012 (from 26.6 to 19.8%) [33], and reductions in total
cholesterol, which declined from 5.4 mmol/L in 1980 to
5.0 mmol/L in 2008 [34]. In contrast, modeling studies
from other LMIC suggest that the main drivers of CHD
mortality are preventable risk factors, such as diet
and physical activity, and improvements in medical
and surgical treatments [5, 12]. In our study, observed
changes in Mexico and Colombia could be similarly
explained by changes in risk factors. For instance, the
reduction of two key two risk factors could explain
changes in mortality rates in Colombia, where smok-
ing decreased from 16.1% in 1980 to 11.2% in 2012,
and total cholesterol in men decreased 1 mmol/L be-
tween 1980 and 2008 [33, 34]. In contrast, in Mexico,
diabetes, BMI and total cholesterol did not have fa-
vorable changes. The prevalence of diabetes increased
68% from 1980 to 2014 (6.5 to 10.9) [35]. BMI in-
creased in men from 25.5 kg/m2 in 1980 to 27.4 kg/
m2 in 2008, and in women from 23.4 kg/m2 to 28.7
kg/m [36]. The contribution of these potential expla-
nations needs to be further studied, taking into con-
sideration the long latency of the disease.
Some important limitations must be mentioned. Like
any other study that uses mortality data across multiple
versions of the International Statistical Classification of
Diseases (ICD), there is potential for attribution bias
owing to both the change between versions of ICD and
the procedures used to code deaths. Vital statistics come
from an independent registry and are subject to errors,
the use of garbage-code correction allows to diminish
the effect of the quality of the information, but other
mechanisms for bias could persist.
Conclusions
Latin America is not a homogeneous region in terms of
CHD mortality. CHD risk factor profiles of each country,
and differences in health care access and quality could
explain some of the observed differences across coun-
tries. While no study of the contribution of these factors
to CHD mortality changes in Latin America has been
conducted, modeling studies from other LMIC suggest
that main drivers of CHD mortality are preventable risk
factors, such as diet and physical activity, and the
remaining part is attributable to improvements in med-
ical and surgical treatments [5, 32]. Furthermore, the
disease burden is even bigger after correcting for mis-
classification, which suggests the need of new strategies
for improving CHD mortality data quality in the region.
Although CHD mortality is falling in Argentina, the
modest falls in Colombia and substantial rises in Mexico
highlight the region’s urgent need for effective
population-wide prevention policies.
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Appendix
Table 1 Age-standardized CHD mortality rates per 100,000 by country. 1985–2015
Sex Argentina Colombia Mexico
Period AMRa Mortality rates
(min-max)
APCb Period AMRa Mortality rates
(min-max)
APCb Period AMRa Mortality rates
(min-max)
APCb
ALL 1985–1988 136.3 133.4–137.8 −0.3 1985–2011 138.7 128.1–160.6 − 0.4^ 1985–1989 89.3 83.3–99.3 6.0^
1988–1994 117.8 103.8–135.2 −5.7^ 2011–2015 141.1 128.3–150.7 4.1^ 1989–1996 111.7 106.7–119.8 2.3^
1994–1999 93.4 89.2–98.1 − 0.4 1996–2007 120.4 117.2–124.8 −0.3
1999–2003 86.1 78.1–95.8 − 5.6^ 2007–2015 128.8 115.4–140.8 2.1^
2003–2009 69.5 62.2–75.1 −2.5^
2009–2015 64.6 62–67.3 0.6
MALE 1985–1988 190.7 186.5–194.8 0.3 1985–2003 168.5 153.8–190.5 −0.7^ 1985–1987 93.0 90.2–95.8 0.5
1988–1994 169.3 153.3–191.3 −4.9^ 2003–2006 162.2 156.4–168.8 2.5 1987–1990 104.6 94.8–111.9 9.3^
1994–1999 138.0 132.5–142.5 −0.9 2006–2011 164.7 158.3–170.1 −1.1 1990–1996 130.4 125.1–137.9 2.1^
1999–2008 115.9 102.4–142.1 −4.0^ 2011–2015 175.6 157.6–186.9 4.7^ 1996–2007 141.1 136.3–145.2 0.1
2008–2015 94.3 91.7–98 0.2 2007–2015 157.0 139–173.1 2.5^
FEMALE 1985–1988 91.8 89.7–93.3 −0.4 1985–2012 113.5 103.5–134 2.5 1985–1989 81.8 76.7–91.9 6.6^
1988–1994 77.5 66.1–91.2 −6.7^ 2012–2015 115.4 104.8–122 −1.1 1989–1992 94.9 90.4–102.5 − 1.6
1994–1999 59.1 56.2–62.6 0 1992–1996 97.6 92.3–102.7 3.5
1999–2004 53.1 47–61.8 −6.4^ 1996–2007 101.3 96.6–105.7 −0.8^
2004–2015 42.2 38.9–44.9 −0.3 2007–2015 104.0 94.2–112.4 1.8^
Periods were identified by joinpoint regression analysis
^p-value < 0.01.
aAMR Average mortality rate
bAPC Annual percentage change
Table 2 Age-standardized garbage- codes corrected CHD mortality rates per 100,000 by country. 1985–2015
Sex Argentina Colombia Mexico
Period AMRa Mortality rates
(min-max)
APCb Period AMRa Mortality rates
(min-max)
APCb Period AMRa Mortality rates
(min-max)
APCb
ALL 1997–1999 183.6 181–186.2 1.2 1997–2003 149.8 142.4–156.4 −1.2 1997–2007 135.0 128.9–142.4 −0.6^
1999–2004 169.2 152.6–187.5 −5.0^ 2003–2006 147.5 144.1–151.6 2.3 2007–2015 138.9 128.2–149.4 1.6^
2004–2012 141.2 132.8–148 −0.6 2006–2011 147.4 140.3–153.3 −2.2







MALE 1997–1999 246.1 242.4–249.8 1.1 1997–2003 177.7 168.6–183.4 −1 1997–2007 154.8 150.8–160.6 −0.2
1999–2004 227.5 207.7–251.7 −4.7^ 2003–2006 177.4 171.5–183.9 2.5 2007–2015 167.0 151.4–182.3 2.1^
2004–2012 187.1 178–196.1 −1.2 2006–2011 178.2 170.5–184.3 − 1.8







FEMALE 1997–1999 135.8 133.5–138.1 1.7 1997–2003 125.2 119.3–132.6 −1.5 1997–2007 116.7 108.4–125.2 −1.1^
1999–2004 125.0 112.2–139.9 −5.3^ 2003–2006 121.4 120.1–123.5 2.2 2007–2015 114.1 107.4–120.4 1.0^
2004–2011 105.9 99.7–111.7 0.2 2006–2011 121.0 114.6–126.6 −2.5







Periods were identified by joinpoint regression analysis.
^p-value < 0.01.
aAMR Average mortality rate.
bAPC Annual percentage change
cAverage percentage change between original and garbage-codes corrected mortality rates
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